Larson Financial Group’s Palvella Therapeutics PVLA Stock Holding History
Bought
Maintained
Sold
Other funds holding PVLA
Larson Financial Group's PVLA Position: Q3 2026 in Review
Larson Financial Group held its Palvella Therapeutics (PVLA) position steady in Q3 2026 at 73 shares worth $10.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2499.
Larson Financial Group first reported a position in PVLA in Q1 2026 and has held it in 3 quarters since. The position peaked at $11.2K in Q2 2026. 196 funds tracked by Wall St. Rank hold PVLA as of Q3 2026.
- Larson Financial Group held 73 shares of Palvella Therapeutics worth $10.1K as of Q3 2026.
- Larson Financial Group left its Palvella Therapeutics share count unchanged in Q3 2026.
- Palvella Therapeutics made up ﹤0.01% of Larson Financial Group's portfolio in Q3 2026, its #2499 holding.
- Larson Financial Group first reported a position in Palvella Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Larson Financial Group's Palvella Therapeutics position peaked at $11.2K in Q2 2026.
- 196 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2026.
Based on Larson Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.